iXpressGenes (iXG), a biotechnology company transforming trauma care, is proud to appoint co-founder John Schmitt as Chief Executive Officer (CEO) and announce the nationwide launch of its Trauma Autoimmune Indicator (TAI) test, available by Q2 2025.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
